Romania Pharmaceuticals and Healthcare Report Q2 2012

Business Monitor International
March 20, 2012
100 Pages - SKU: BMI3816816
Executive Summary
SWOT Analysis
Romania Pharmaceuticals And Healthcare Industry SWOT
Romania Political SWOT
Romania Economic SWOT
Romania Business Environment SWOT
Pharmaceutical Risk/Reward Ratings
Table: Emerging Europe – Regional Pharmaceutical Risk/Reward Ratings, Q212
Romania – Market Summary
Regulatory Regime
Intellectual Property Issues
Reimbursement Regime
Reimbursement Regime Developments
Claw-back Tax
Pricing Regime
Industry Developments
Healthcare Sector
Possible Delays To Further Healthcare Reforms
Approved Healthcare Reforms In Brief
Drafted But Withdrawn Structural Healthcare Reforms
Private Healthcare Services
Payment Delays
Industry Forecast Scenario
Overall Market Forecast
Table: Pharmaceutical Sales Indicators 2008-2016
Key Growth Factors – Industry
Table: Healthcare Expenditure Indicators 2008-2016
Table: Healthcare Governmental Indicators 2008-2016
Table: Healthcare Private Indicators 2008-2016
Macroeconomic Forecast Scenario
Romania – Economic Activity
Prescription Drug Market Forecast
Table: Prescription Drug Sales Indicators 2008-2016
Patented Drug Market Forecast
Table: Patented Drug Market Indicators 2008-2016
Generic Drug Market Forecast
Table: Generic Drug Sales Indicators 2008-2016
OTC Medicine Market Forecast
Table – Romania OTC Medicine Sub-Sector Market
Table: OTC Medicine Sales Indicators 2008-2016
Pharmaceutical Trade Forecast
Table: Exports and Imports Indicators 2008-2016
Medical Device Market Forecast
Table: Medical Devices Sales Indicators 2008-2016
Key Risks to BMI’s Forecast Scenario
Competitive Landscape
Pharmaceutical Industry
Pharmaceutical Company Activities
Company Monitor
Indigenous Companies
Zentiva Romania
Actavis Romania (Sindan)
Antibiotice Iasi
LaborMed Pharma
Foreign Companies
GlaxoSmithKline (Europharm)
Merck & Co
Country Snapshot: Romania Demographic Data
Section 1: Population
Section 2: Education and Healthcare
Table: Vital Statistics, 2005-2030
Section 3: Labour Market and Spending Power
Table: Employment Indicators, 2001-2006
Table: Consumer Expenditure, 2005-2010 (US$)
Table: Average Annual Wages, 2006-2010
BMI Methodology
How We Generate Our Pharmaceutical Industry Forecasts
Pharmaceuticals Business Environment Ratings
Risk/Reward Ratings Methodology
Ratings Overview
Table: Pharmaceutical Business Environment Indicators
Table: Weighting Of Components


    Report with 3 quarterly updates  USD 1,175  
US: 800.298.5699
Int'l: +1.240.747.3093

Share this report

    Other tasks

    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!